Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-23-000324
Filing Date
2023-03-23
Accepted
2023-03-23 16:05:54
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS gild4141721-defa14a.htm DEFA14A 37848
2 GRAPHIC gild4141721-defa14a1x1.jpg GRAPHIC 55917
3 GRAPHIC gild4141721-defa14a1x2.jpg GRAPHIC 5163
4 GRAPHIC gild4141721-defa14a1x3.jpg GRAPHIC 3186
5 GRAPHIC gild4141721-defa14a1x4.jpg GRAPHIC 7360
6 GRAPHIC gild4141721-defa14a1x5.jpg GRAPHIC 6871
7 GRAPHIC gild4141721-defa14a2x1a.jpg GRAPHIC 1098
8 GRAPHIC gild4141721-defa14a2x1b.jpg GRAPHIC 1098
9 GRAPHIC gild4141721-defa14a2x2.jpg GRAPHIC 1093
10 GRAPHIC gild4141721-defa14a2x3.jpg GRAPHIC 1102
11 GRAPHIC gild4141721_logo.jpg GRAPHIC 12724
  Complete submission text file 0001308179-23-000324.txt   172206
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19731 | Film No.: 23756219
SIC: 2836 Biological Products, (No Diagnostic Substances)